About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Chicago | 233 Studies

Clinical Trials MelanomaChicago

Melanoma Clinical Trials in Chicago

Find 233 clinical trials for melanoma near Chicago, Illinois. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 233 trials

CompletedAn Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by ItselfThis is a study of Nivolumab combined with Ipilimumab followed by Nivolumab by itself for the treatment of patients with Melanoma that has spread to the brain.NCT02320058·Duarte, California and 35 others

Melanoma Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPhase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsThis phase I trial using the EffTox design will evaluate activity and safety of alisertib, an Aurora A kinase inhibitor, when given in combination with the selective VEGFR…NCT01639911·Chicago, Illinois

CompletedDetection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With MelanomaRATIONALE: Diagnostic procedures may improve the ability to detect the presence or recurrence of disease.NCT00004153·Chicago, Illinois

Active not recruitingA Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced MelanomaThe purpose of this study is to determine whether relatlimab in combination with nivolumab is more effective than nivolumab monotherapy in treating unresectable melanoma or…NCT03470922·Tucson, Arizona and 126 others

CompletedStudy to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersThe purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers.NCT02178722·La Jolla, California and 23 others

CompletedTraining Primary Care Physicians to Perform Melanoma Opportunistic SurveillanceThis is a four-phase educational intervention for primary care practitioners (PCPs) to perform opportunistic melanoma surveillance.NCT02385253·Chicago, Illinois and 1 other

CompletedA Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV MelanomaThe purpose of this clinical research study is to evaluate the Best Overall Response Rate (BORR), (as per modified WHO criteria) in patients with previously treated melanoma-Stage…NCT00289627·Little Rock, Arkansas and 52 others

CompletedStudy of Talabostat in Advanced MelanomaThe purpose of this study is to assess the antitumor activity and safety of talabostat in patients with metastatic melanoma.NCT00083239·Atlanta, Georgia and 5 others

RecruitingA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsThis is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors.NCT06172478·Duarte, California and 93 others

CompletedAn Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV MelanomaThe purpose of this study is to determine whether an investigational immunotherapy Nivolumab, when combined with Ipilimumab, is more effective than Nivolumab by itself, in…NCT03068455·Tucson, Arizona and 123 others

CompletedDasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryRATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00700882·Little Rock, Arkansas and 152 others

TerminatedA Study of SGN-CD228A in Advanced Solid TumorsThis trial will study SGN-CD228A to find out whether it is an effective treatment for different kinds of cancer.NCT04042480·Birmingham, Alabama and 13 others

CompletedRapamycin With Grapefruit Juice for Advanced MalignanciesThe purpose of this study is to determine the highest safe dose of rapamycin when given with a fixed amount of grapefruit juice.NCT00375245·Chicago, Illinois

TerminatedStudy to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for RecurrenceThe main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage IIIA/B/C/D, or Stage IV…NCT04410445·Scottsdale, Arizona and 211 others

Active not recruitingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyThe 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by…NCT03589339·San Francisco, California and 12 others

CompletedCombination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004141·Chicago, Illinois

CompletedDERM US and EU Validation StudyThis study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to…NCT05126173·Redwood City, California and 15 others

CompletedBiological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other TumorsRATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protein use different ways to stimulate the immune system and stop cancer cells from growing.NCT00003750·Little Rock, Arkansas and 58 others

CompletedImmunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])The purpose of this research study is to evaluate the effectiveness of transplantation of high doses of peripheral blood stem cells (stem cells are special cells found in the…NCT00179764·Chicago, Illinois

CompletedIpilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well ipilimumab with or without high-dose recombinant interferon alpha-2b works in treating patients with stage III-IV melanoma that…NCT01708941·Birmingham, Alabama and 275 others

PreviousPage 10 of 12Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma